awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37424419-5D8EC432-8ECA-4491-8FC1-8C90C4ADFDAC
Q37424419-5D8EC432-8ECA-4491-8FC1-8C90C4ADFDAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37424419-5D8EC432-8ECA-4491-8FC1-8C90C4ADFDAC
Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression.
P2860
Q37424419-5D8EC432-8ECA-4491-8FC1-8C90C4ADFDAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37424419-5D8EC432-8ECA-4491-8FC1-8C90C4ADFDAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d91f0308b9ad2bc1f5463f0598d7d0bcb8319fa
P2860
Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: a randomised non-inferiority trial of degarelix versus